Merck & Co., Inc. (MRK) Special Event (Oncology Investor Event at ASCO 2023) Transcript

Merck & Co., Inc. (NYSE:MRK) Special Event (Oncology Investor Event at ASCO 2023) June 5, 2023 7:00 PM ET Company Participants Peter Dannenbaum - VP, IR Dean Li - President, Merck Research Laboratories Eliav Barr - SVP, Head of Global Clinical Development & Chief Medical Officer Gregory Lubiniecki - VP, Late-Stage Oncology Development Marjorie Green - SVP, Head of Late Oncology Development Chirfi Guindo - Chief Marketing Officer Scot Ebbinghaus - VP, Late Oncology Development Conference Call Participants Tr ...